Vanderbilt University Medical Center

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Vanderbilt University Medical Center sits in the top decile of US sponsors by registered trial count (#51 of 15,742 sponsors by registered trial count).

677 total trials 130 currently recruiting 400 completed early-phase tilt top decile by trial count

Vanderbilt University Medical Center: 677 sponsored US clinical trials, 130 recruiting.

Vanderbilt University Medical Center sponsors 677 registered US clinical trials on ClinicalTrials.gov, 130 of them currently recruiting, and 400 completed. 70 of these trials are in Phase 3-4 (later-stage) and 127 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autonomic Failure, with 9 trials.

Top-decile sponsor footprint

Vanderbilt University Medical Center ranks in the top decile of sponsors by registered trial count (#51 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 54/100

400 of 467 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

677 total, page 13 of 14

COMPLETED NA

A Computerized Asthma Management System in the Pediatric Emergency Department

NCT01070147

COMPLETED

Childhood Cancer Survivors' Knowledge of Diagnosis,Treatment and Risk of Late Effects: Specialized Survivorship Clinic

NCT01223872

COMPLETED

Ceftriaxone in Non-neutropenic Fever

NCT01225718

TERMINATED Phase 4

Use of Dapsone Gel, 5% for Treating Dermatitis Herpetiformis

NCT01115244

COMPLETED Phase 2

Pilot Trial of Statin Use in Burn Patients

NCT00978419

COMPLETED Phase 1

Aldosterone and the Metabolic Syndrome

NCT01103245

COMPLETED

Yoga Intervention for Cancer Survivors

NCT01228955

COMPLETED Phase 4

Descriptive Study of Cardiac Output During Rehydration With Recombinant Human Hyaluronidase in Pediatrics

NCT01139294

COMPLETED Phase 1

Pathophysiology of Cardiometabolic Risk Factors in African Americans

NCT01122407

COMPLETED

Identification of Inpatients at Risk for Poor Glycemic Control

NCT01043042

COMPLETED

Anterior Cruciate Ligament (ACL) Reconstruction- Bioabsorbable Screw

NCT01069588

TERMINATED NA

Comparison Study of Two Different Surgical Clips During Laparoscopic Urologic Surgery

NCT01008709

COMPLETED

Study of Effects of L-Arginine in Colitis and Colon Cancer

NCT01091558

COMPLETED NA

A Reminder System for Paper-Based Asthma Guidelines in the Pediatric Emergency Department

NCT00699439

COMPLETED NA

Short-term Atorvastatin's Effect on Acute Kidney Injury Following Cardiac Surgery

NCT00791648

COMPLETED

Effectiveness of a Walking Program Modulating Cardioreparative Factors in Heart Failure

NCT00937443

COMPLETED

Delirium in the Emergency Department: Novel Screening

NCT01162343

COMPLETED Phase 4

The Effects of Renin Inhibition on Fibrinolytic Balance and Endothelial Function

NCT03115853

COMPLETED Phase 4

Intraoperative Infusion of Precedex to Reduce Length of Stay After Lumbar Spine Fusion

NCT00808665

COMPLETED

Joint Pain and Medication Adherence in Postmenopausal Women Receiving Aromatase Inhibitors

NCT00954564

COMPLETED NA

Skeletal Versus Cutaneous Traction For Treatment of Femur Fractures

NCT00916136

COMPLETED Phase 1

The Renin-Aldosterone Axis in Postural Tachycardia Syndrome

NCT00962949

COMPLETED Phase 4

Use of Omega-3 Fat Emulsion (Omegaven) in Infants With Parenteral Nutrition Associated Liver Disease

NCT00862446

COMPLETED NA

Medium-term Venous Access in Congenital Heart Surgery

NCT00852488

TERMINATED Phase 1

How Your Patients' Non-REM Sleep Changes On Sedatives in the Intensive Care Units

NCT00826553

COMPLETED

Kidney Dysfunction in Children and Young Adults Who Have Received Methotrexate for Acute Lymphoblastic Leukemia

NCT00993135

COMPLETED

Metabolic Syndrome in Young Patients With Acute Lymphoblastic Leukemia in Remission

NCT00801346

COMPLETED

MRI Imaging of Chronobiologic Abnormalities in Depression

NCT00178880

COMPLETED NA

Angiotensin Converting Enzyme Inhibitors During Cardiopulmonary Bypass in Infants and Children

NCT00848250

COMPLETED

Inflammation and Risk Prediction in Patients With Abdominal Aortic Aneurysm

NCT00513773

COMPLETED NA

Pharmacist Intervention to Decrease Medication Errors in Heart Disease Patients (The PILL-CVD Study)

NCT00632021

COMPLETED Phase 3

Pediatric Tonsillectomy Pain Reduction Study

NCT00678379

COMPLETED

Validation of the NTX Wireless Patient Monitoring System

NCT00644644

COMPLETED

Serum Markers of Ischemia Reperfusion Injury in Liver Transplant Patients

NCT00698399

TERMINATED NA

Microneurography and Spinal Cord Stimulation in Chronic Visceral Pain

NCT00678717

COMPLETED Phase 4

Endoscopic Ultrasound (EUS) Guided Treatment With Humira for Crohn's Perianal Fistulas

NCT00517296

COMPLETED

Prognostic Value of Transforming Growth Factor-Beta 1 in Normal Pressure Hydrocephalus

NCT00600795

COMPLETED NA

Olopatadine Eye Drops and Allergy Skin Testing

NCT00775658

TERMINATED NA

Autonomic Dysfunction and Spinal Cord Stimulation in Complex Regional Pain Syndrome

NCT00780390

COMPLETED Phase 4

Effect of Valproic Acid Concentration on Photic Response

NCT00609245

COMPLETED

Neurocognitive Functioning in Patients With Newly Diagnosed Upper Aerodigestive Tract Cancer Receiving Treatment at Henry-Joyce Cancer Clinic

NCT00533884

TERMINATED Phase 4

The Use of an Acellular Dermal Matrix in a Two-Staged Breast Reconstruction

NCT00616824

COMPLETED NA

Urinary Prostaglandin E Metabolite (PGE-M), A Metabolite of Prostaglandin E2 (PGE2): A Novel Biomarker of Crohn's Disease Activity

NCT00496548

COMPLETED NA

The SOMNUS Study: Sedative Optimization Via Monitoring Neurological Status

NCT00469482

COMPLETED Phase 4

Diurnal Variation of Plasminogen Activator Inhibitor-1

NCT00515021

COMPLETED Phase 2

The Effect of Nebulized Albuterol on Donor Oxygenation

NCT00310401

TERMINATED Phase 3

Acetaminophen in aSAH to Inhibit Lipid Peroxidation and Cerebral Vasospasm

NCT00585559

COMPLETED Phase 1

Characteristics of Glargine in Type 2 Diabetics

NCT00574912

COMPLETED Phase 4

Do Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux Predict Response to Treatment?

NCT00444145

COMPLETED Phase 1

PET Imaging and Bariatric Surgery

NCT00801827

← Previous Page 13 of 14 Next →

Phase Distribution

PhaseTrial count
Phase 1 65
Phase 2 62
Phase 3 14
Phase 4 56

What is open in the Vanderbilt University Medical Center pipeline

130 recruiting of 677 indexed (19% open); 400 completed (59%).

Phase mix: 70 late (III/IV) vs 127 early (I/II) (early-phase heavy).

Top condition: Autonomic Failure (9 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Vanderbilt University Medical Center: open-pipeline peers nationwide

Peers matched on 677 registered trials and 19% open enrollment, not the therapeutic-area sidebar.

Vanderbilt University Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 01,0002,0003,000 12%14%16%18%20%22%24% Total trials Recruiting share Vanderbilt University Medical CenterThe Cleveland ClinicUniversity of California, DavisWeill Medical College of Cornell UniversityIcahn School of Medicine at Mount SinaiCalifornia Polytechnic State University-San Luis ObispoPhoenix Children's HospitalMayo ClinicUniversity of South Carolina
Vanderbilt University Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Vanderbilt University Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 677 trials (± recruiting share)

Sponsors near 19% open enrollment (± trial volume)

What to do with this Vanderbilt University Medical Center page

677 registered trials is a research-attention snapshot, not an endorsement of Vanderbilt University Medical Center or any single study.

  • 130 of Vanderbilt University Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Autonomic Failure is the condition Vanderbilt University Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Autonomic Failure trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Vanderbilt University Medical Center pipeline card: 677 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.